Showing results (151-160 of 310) with videos related to

Sort By:
Pageof 31
American Journal of Hematology|January 1, 1978
A new mutant erythrocyte glucosephosphate isomerase (GPI) associated with GSH abnormalityA Zanella, P Rebulla, C Izzo, et al.
Acta Dermato-Venereologica. Supplementum|January 1, 1994
Experience with psoriasis in a psychosomatic dermatology clinicM M Polenghi, E Molinari, C Gala, et al.
Haematologica|July 1, 1989
Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in a hematological/oncological outpatient sectionA Riccardi, M Danova, L Quartero, et al.
Translational Psychiatry|June 13, 2019
Correction: Regulation of dopaminergic function: An [18F]-DOPA PET apomorphine challenge study in humansS Jauhar, M Veronese, M Rogdaki, et al.
Translational Psychiatry|September 2, 2018
Correction: Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humansS Jauhar, M Veronese, M Rogdaki, et al.
Annales De Dermatologie Et De Venereologie|May 8, 2007
[Acute hepatitis during primary herpes simplex type 2 infection in a patient with systemic lupus erythematosus]N Kluger, D Boutboul, E Molinari, et al.
Recenti Progressi in Medicina|May 6, 1999
[An increased prevalence of thyroid echographic and autoimmune changes in hyperprolactinemic women on therapy with dopaminergic drugs]M Giusti, L Foppiani, L Fazzuoli, et al.
Journal of Endocrinological Investigation|April 2, 2004
Circulating nitric oxide is modulated by recombinant human TSH administration during monitoring of thyroid cancer remnantM Giusti, S Valenti, B Guazzini, et al.
Eicosanoids|January 1, 1992
Aspirin abolishes the decreased low-density lipoprotein (LDL) entry into the rabbit arterial wall induced by the calcium channel blocker isradipineH Sinzinger, I Virgolini, J O'Grady, et al.
Journal of Cardiovascular Pharmacology|April 1, 1991
Isradipine, a calcium-entry blocker, decreases vascular [125-I]low-density lipoprotein entry in hypercholesterolemic rabbitsH Sinzinger, G Lupattelli, I Virgolini, et al.
Pageof 31